Literature DB >> 25558798

Predictors of quality of life in patients with relapsing-remitting multiple sclerosis: a 2-year longitudinal study.

K Baumstarck1, J Pelletier2, M Boucekine3, P Auquier2.   

Abstract

INTRODUCTION: Knowledge of which factors are determinant of quality of life (QoL) in patients with multiple scleroris (MS) would assist clinicians in choosing the most appropriate interventions. The aim of this study was to determine the contribution of sociodemographic and clinical factors in the predicting QoL in a 2-year cohort of patients with relapsing-remitting MS (RR-MS).
METHODS: The study had a multi-center, multi-regional, and longitudinal design. Main inclusion criteria were: patient with a RR-MS subtype (McDonald criteria) and an Expanded Disability Status Scale (EDSS) score lower than 7.0. Sociodemographic (age, gender, education level, marital and employment status) and clinical (disability, disease duration, relapse) data were recorded. The QoL was assessed using the MusiQoL (disease-specific) and SF-36 (generic) questionnaires. Each patient was investigated at baseline and 24 months post-inclusion (ClinicalTrials.gov identifier: NCT00702065).
RESULTS: Five hundred and twenty-six patients were enrolled in the present study. The 24-month MusiQoL index score was significantly inversely correlated with the disease duration. Baseline EDSS score impacted in both 'physical-like' and 'psychological-like' dimensions. At least one relapse during the follow-up period was associated with lower physical scores. Occupational status and marital status were associated with 24-month scores of MusiQoL and SF-36.
CONCLUSION: After adjusting for disability and relapse occurrence, sociodemographics (age, marital status, and occupational status) and baseline QoL scores were also independent QoL predictors in MS patients. Special attention should be given to subgroups to ensure optimal management.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Longitudinal study; Multiple sclerosis; MusiQoL; Paramètres; Predictors; Quality of life; Qualité de la vie; SF-36; Sclérose en plaques; Étude longitudinale

Mesh:

Year:  2015        PMID: 25558798     DOI: 10.1016/j.neurol.2014.09.005

Source DB:  PubMed          Journal:  Rev Neurol (Paris)        ISSN: 0035-3787            Impact factor:   2.607


  10 in total

1.  Peginterferon beta-1a reduces disability worsening in relapsing-remitting multiple sclerosis: 2-year results from ADVANCE.

Authors:  Scott D Newsome; Bernd C Kieseier; Shifang Liu; Xiaojun You; Elizabeth Kinter; Serena Hung; Bjoern Sperling
Journal:  Ther Adv Neurol Disord       Date:  2016-11-16       Impact factor: 6.570

Review 2.  Evolution of Patient-Reported Outcomes and Their Role in Multiple Sclerosis Clinical Trials.

Authors:  Cindy J Nowinski; Deborah M Miller; David Cella
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

3.  Sex differences in predictors of illness intrusiveness in persons with multiple sclerosis.

Authors:  Lindsay O Neto; Elizabeth S Gromisch; Jessica Sloan; Tuula Tyry; Frederick W Foley
Journal:  Qual Life Res       Date:  2018-10-17       Impact factor: 4.147

4.  Long-term quality of life in treatment-resistant depression after electroconvulsive therapy.

Authors:  Heidemarie Lex; Steven W Nevers; Erica L Jensen; Yarden Ginsburg; Daniel F Maixner; Brian J Mickey
Journal:  J Affect Disord       Date:  2021-05-18       Impact factor: 6.533

Review 5.  An update on the use of natalizumab in the treatment of multiple sclerosis: appropriate patient selection and special considerations.

Authors:  Barbara Kornek
Journal:  Patient Prefer Adherence       Date:  2015-05-19       Impact factor: 2.711

6.  The impact of disease characteristics on multiple sclerosis patients' quality of life.

Authors:  Aziz Rezapour; Abdollah Almasian Kia; Sahar Goodarzi; Mojtaba Hasoumi; Soraya Nouraei Motlagh; Sajad Vahedi
Journal:  Epidemiol Health       Date:  2017-02-19

7.  Quality of life in adults with multiple sclerosis: a systematic review.

Authors:  Irene Gil-González; Agustín Martín-Rodríguez; Rupert Conrad; María Ángeles Pérez-San-Gregorio
Journal:  BMJ Open       Date:  2020-11-30       Impact factor: 2.692

8.  Neural substrate of quality of life in patients with schizophrenia: a magnetisation transfer imaging study.

Authors:  Catherine Faget-Agius; Faget-Agius Catherine; Laurent Boyer; Jonathan Wirsich; Wirsich Jonathan; Jean-Philippe Ranjeva; Ranjeva Jean-Philippe; Raphaelle Richieri; Richieri Raphaelle; Elisabeth Soulier; Soulier Elisabeth; Sylviane Confort-Gouny; Confort-Gouny Sylviane; Pascal Auquier; Auquier Pascal; Maxime Guye; Guye Maxime; Christophe Lançon; Lançon Christophe
Journal:  Sci Rep       Date:  2015-12-03       Impact factor: 4.379

9.  Psychosocial and Medical Determinants of Health-related Quality of Life in Patients with Relapsing-Remitting Multiple Sclerosis.

Authors:  Isaac Rahimian Boogar; Siavash Talepasand; Mohammad Jabari
Journal:  Noro Psikiyatr Ars       Date:  2018-03-19       Impact factor: 1.339

10.  Evobrutinib, a covalent Bruton's tyrosine kinase inhibitor: Mass balance, elimination route, and metabolism in healthy participants.

Authors:  Holger Scheible; Martin Dyroff; Annick Seithel-Keuth; Eleanor Harrison-Moench; Nadra Mammasse; Andreas Port; Angelika Bachmann; Jennifer Dong; Jan Jaap van Lier; William Tracewell; David Mitchell
Journal:  Clin Transl Sci       Date:  2021-08-10       Impact factor: 4.689

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.